{"bill":{"bill_id":1356747,"change_hash":"2c6a9b83c875ac6561117f5f64189c4b","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB6102\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/6102\/all-info","completed":0,"status":1,"status_date":"2020-03-05","progress":[{"date":"2020-03-05","event":1},{"date":"2020-03-05","event":9}],"state":"US","state_id":52,"bill_number":"HB6102","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"VALID Act of 2020 Verifying Accurate Leading-edge IVCT Development Act of 2020","description":"To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.","pending_committee_id":2302,"committee":{"committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},"referrals":[{"date":"2020-03-05","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2020-03-05","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-03-05","action":"Referred to the House Committee on Energy and Commerce.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":8967,"person_hash":"klyveg3n","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Diana DeGette","first_name":"Diana","middle_name":"","last_name":"DeGette","suffix":"","nickname":"","district":"HD-CO-1","ftm_eid":6006202,"votesmart_id":561,"opensecrets_id":"N00006134","knowwho_pid":158770,"ballotpedia":"Diana_DeGette","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":11042,"person_hash":"q6aavo7l","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Larry Bucshon","first_name":"Larry","middle_name":"","last_name":"Bucshon","suffix":"","nickname":"","district":"HD-IN-8","ftm_eid":7004017,"votesmart_id":120335,"opensecrets_id":"N00031227","knowwho_pid":284631,"ballotpedia":"Larry_Bucshon","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":1,"type":"Same As","sast_bill_number":"SB3404","sast_bill_id":1356729}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13126,"subject_name":"Administrative law and regulatory procedures"},{"subject_id":13384,"subject_name":"Administrative remedies"},{"subject_id":13127,"subject_name":"Advisory bodies"},{"subject_id":13146,"subject_name":"Congressional oversight"},{"subject_id":13156,"subject_name":"Department of Health and Human Services"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13308,"subject_name":"Emergency medical services and trauma care"},{"subject_id":13185,"subject_name":"Federal preemption"},{"subject_id":13787,"subject_name":"Food and Drug Administration (FDA)"},{"subject_id":13200,"subject_name":"Government information and archives"},{"subject_id":13214,"subject_name":"Health technology, devices, supplies"},{"subject_id":13312,"subject_name":"Licensing and registrations"},{"subject_id":13313,"subject_name":"Medical tests and diagnostic methods"},{"subject_id":13258,"subject_name":"Performance measurement"},{"subject_id":13648,"subject_name":"User charges and fees"}],"texts":[{"doc_id":2173251,"date":"2020-03-17","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB6102\/id\/2173251","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr6102\/BILLS-116hr6102ih.pdf","text_size":698357,"text_hash":"e710be0cb6e43d058a2107aa0219cc47"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}